New Coverage Decision Extends Abbott’s Innovative Pain Therapy Option to 22 Million Americans Living with Chronic Pain
Abbott (NYSE : ABT ) today...
Read MoreFortis Memorial Research Institute ,...
Read MoreLEO Pharma and Bayer announced...
Read MoreResearchers at Cleveland Clinic, University...
Read MoreThe foundation stone for a...
Read MoreEurofins Scientific (EUFI.PA), a global...
Read MoreUnited Therapeutics has agreed to...
Read MoreArrowhead Pharmaceuticals Inc. (NASDAQ: ARWR)...
Read MoreShire’s oncology business includes in-market...
Read MoreFor many years, researchers have...
Read More